Cross species comparison, stability investigations, SAD Met ID are examples of ongoing studies at MetaSafe
9 February, 2016
MetaSafe Strengthens the Team
18 November, 2015
We are delighted to announce the appointment of our new team member Dr. Magnus Halldin. Magnus is now appointed as Scientific Advisor for MetaSafe in the DMPK (ADME) area in which Magnus possesses 30 years of experience.
Magnus has a Master’s degree in Pharmacy from School of Pharmacy, University of Uppsala, Uppsala 1977 and a PhD in Pharmacognosy (Thesis: Biotransformation of Tetrahydrocannabinol in Man and Animal) from University of Uppsala, 1982.
After postdoctoral studies at School of Pharmacy, University of California, San Francisco, USA, Magnus Halldin joined Astra (AstraZeneca) in 1985, where he up to 2013 held various line, project and scientific management positions in the company. Magnus also had a scientific DMPK advisory role on numerous global scientific committees and knowledge groups, and in-licensing and due diligence opportunities within both Discovery and Development.
His appointment is a valuable addition to the team and a perfect complement to our analytical service within the DMPK area in both discovery and development.
Meet us at Pharma Outsourcing 2015 at Waterfront, Stockholm, December 9.
19 October, 2015
MetaSafe was accepted to UIC Business Accelerator in August. This journey is now ongoing.
19 September, 2015
Research Service Agreement signed with a big pharmaceutical company. MetaSafe looks forward to fruitful collaboration.
8 August, 2015
MetaSafe continues to contribute to MIST evaluations at different phases in Development
4 March, 2015
This is done through in vitro, in vivo, qualitative and quantitative assessments of metabolites in different set ups depending on which phase the project is heading. Although there is a general approach based on guidelines, all approaches are project dependent. MetaSafe plays an important role, helping customers to understand prerequisites of their projects. Together with the customers we find out the most pragmatic approach to evaluate, at different phases, the risk for MIST issues and how to continue to increase the confidence of such evaluations step by step.
Utilize our Top 3 Metabolite Characterization Approach to support your redesign of molecules to enhance metabolic stability
7 January, 2015
MetaSafe wishes You All a Happy New Year!
1 January, 2015
It has been an intense year for MetaSafe where we have been involved in a huge variety of projects where we have contributed with biotransformation work.
Metabolic Stability, Metabolite Characterization Screen, Reactive Metabolite Investigations, In Vivo Metabolite Characterization studies, MIST (Metabolites in Safety Testing) studies and Method Developments for Endogenous Metabolites and ADME support are examples of deliverables.
We look forward to continue existing collaborations and welcome new exciting projects.